1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thromboxanes

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with thromboxanes in 84 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (thromboxanes)	Trials (thromboxanes)	Recent Studies (post-2010) (thromboxanes)
9,156	187	552	3,202	149	199

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	47 (55.95)	18.7374
1990's	29 (34.52)	18.2507
2000's	8 (9.52)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Lima, WT; Jancar, S; Sirois, P	1
Manning, PJ; O'Byrne, PM	1
Catto-Smith, AG; Gall, DG; MacNaughton, WK	1
Henderson, WR	1
Dyson, MC; Kadowitz, PJ	1
Croset, M; Fonlupt, P; Lagarde, M	1
Fukutomi, H; Nakahara, A; Shimakura, S	1
Daniel, EE; O'Byrne, P	1
Downey, GP; Hellewell, PG; Henson, PM; Worthen, GS	1
Braquet, P; Plante, GE; Sirois, MG; Sirois, P	1
Egan, RW; Fernandez, X; Gulbenkian, AR; Kreutner, W; Kung, T; Minnicozzi, M; Watnick, AS	1
Duddridge, M; Harris, A; Hendrick, DJ; Palmer, JB; Stenton, SC; Walters, EH; Ward, C	1
Esser, KM; Farhat, M; Feuerstein, G; Rabinovici, R; Slivjak, M; Smith, EF; Yue, TL	1
McCall, CE; Salzer, WL	1
Inada, Y; Kojima, S; Saito, Y; Sekiya, F; Tsukada, T	1
Wallace, JL	1
Eyre, P; Ogunbiyi, PO	1
Bayer, T; Dorsch, W; Fessler, B; Hein, G; Ring, J; Scheftner, P; Sieber, W; Strasser, T; Wagner, H; Weiss, E	1
Pacitti, N; Parratt, JR; Rodger, IW	1
Atkinson, PM; Hofmeyr, GJ; Rodrigues, FA; Sonnendecker, EW	1
Hébert, RL; Plante, GE; Sirois, P	1
Benveniste, J; Delautier, D; Keraly, CL	1
McDonald, JW; Smallbone, BW; Taylor, NE	1
Goto, F	1
Barden, A; Beilin, LJ; Codde, JP; Croft, KD; Vandongen, R	1
Alijani, MR; Foegh, ML; Hartmann, DP; Helfrich, GB; Khirabadi, BS; Ramwell, PW; Rowles, JR	1
Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A	1
Bushfield, M; MacIntyre, DE; MacMillan, LJ; McNicol, A; Pollock, WK; Shaw, AM	1
Aizawa, H; Chung, KF; Evans, TW; Leikauf, GD; Nadel, JA; Ueki, IF	1
Rink, TJ	1
Foegh, ML	1
Borgeat, P; Braquet, P; Harczy, M; Maclouf, J; Pradelles, P; Sirois, P	1
Frölich, JC; Küster, LJ	1
Akkerman, JW; Kloprogge, E	1
Ezra, D; Feuerstein, G; Goldstein, RE; Hayes, E; Ramwell, PW	1
Braquet, P; Jancar, S; Plante, GE; Sirois, MG; Sirois, P	1
Vanhoutte, PM	1
Alijani, MR; Foegh, ML; Helfrich, GB; Khirabadi, BS; Ramwell, PW	1
Mest, HJ; Riedel, A; Schneider, S	1
Hardisty, RM; Powling, MJ	1
Alessandri, C; Cordova, C; Ghiselli, A; Praticò, D; Violi, F	1
Peskar, BA; Simmet, T	1
Houston, DS; Vanhoutte, PM	1
Chap, H; Douste-Blazy, L	1
Cazenave, JP; d'Humières, S; Hemmendinger, S; Russo-Marie, F	1
Bach, MK	1
Donlon, MA; Kaliner, M; Metcalfe, DD	1
Green, A; Haddad, ZH	1
Benveniste, J; Fouque, F; Joseph, D; Odiot, J; Vargaftig, BB	1
Ayer, DE; Gorman, RR; Miller, OV	1
Dyerberg, J; Jørgensen, KA	1
Hartung, HP	1
Lefort, J; Rotilio, D; Vargaftig, BB	1
Dangelmaier, C; Hassell, B; Holmsen, H; Rao, AK; Smith, JB; Willis, J	1
Vargaftig, BB	1
Hamasaki, Y; Said, SI; Tai, HH	1
Myśliwiec, B; Myśliwiec, M	1
Fitzpatrick, FA; Hanahan, DJ; McManus, LM; Pinckard, RN	1
Canham, EM; Heffner, JE; McMurtry, IF; Morris, HG; Patel, M; Repine, JE; Shoemaker, SA	1
Benveniste, J; Chignard, M; Vargaftig, BB	1
Fouque, F; Joseph, D; Vargaftig, BB	1
Hanahan, DJ; Klusick, SJ; Shaw, JO	1
Crawford, MH; Fitzpatrick, FA; Hanahan, DJ; McManus, LM; O'Rourke, RA; Pinckard, RN	1
Fletcher, JR; Khimenko, PL; Logsdon, P; Rizzo, A; Taylor, AE; Townsley, MI	1
Barnes, NC	1
Uhlig, S; Wendel, A; Wollin, L	1
Bretschneider, E; Glusa, E; Schrör, K	1
Bernard, GR; Christman, BW	1
Kuo, YH; Lin, CH; Lin, YL; Teng, CM	1
Gulbins, E; Rauterberg, EW; Schlottmann, K; Steinhausen, M	1
Featherstone, RL; Uhlig, S; Wendel, A; Wilhelms, OH	1
Fukuchi, Y; Ishii, S; Katayama, H; Nagase, T; Ouchi, Y; Shimizu, T	1
Koyama, S; Miyahara, T; Shibamoto, T; Wang, HG	1
Hawkey, CJ; Stack, WA	1
Delong, P; Hubbard, CL; Huggins, E; McCall, C; O'Sullivan, MG	1
Gilani, AH; Mahmood, H; Nawaz, Z; Pertani, SA; Roomi, A; Saeed, SA; Shah, BH	1
László, F; Morschl, E; Nemcsik, J; Pávó, I; Pozsár, J; Whittle, BJ	1
Fegbeutel, C; Gokorsch, S; Grimminger, F; Hattar, K; Heuer, KU; Krämer, HJ; Mayer, K; Seeger, W; Sibelius, U; Temmesfeld-Wollbrück, B	1
Göggel, R; Martin, C; Ressmeyer, AR; Uhlig, S	1
Hla, T	1
Chen, CC; Hsu, HC; Huang, HY; Tsai, WJ; Tsai, YC; Yang, WC	1
Bailey, SR; Cunningham, FM; Hammond, A; Marr, CM	1
Bailey, SR; Brooks, AC; Cunningham, FM; Elliott, J; Menzies-Gow, NJ; Wheeler-Jones, CP	1
Frey, M; Herndon, DH; Jeschke, MG; Kamolz, LP; Keck, M	1

Reviews

21 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thromboxanes

Article	Year
Clinical relevance of lipid mediators in asthma. The Journal of asthma : official journal of the Association for the Care of Asthma, 1992, Volume: 29, Issue:3 Topics: Animals; Arachidonic Acid; Asthma; Humans; Leukotrienes; Lipids; Platelet Activating Factor; Prostaglandins; Thromboxanes	1992
Eicosanoids and platelet-activating factor in allergic respiratory diseases. The American review of respiratory disease, 1991, Volume: 143, Issue:5 Pt 2 Topics: Arachidonate 5-Lipoxygenase; Eicosanoids; Eosinophils; Humans; Leukotrienes; Macrophages; Neutrophils; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Respiratory Hypersensitivity; Thromboxanes	1991
Lipid mediators of inflammation in gastric ulcer. The American journal of physiology, 1990, Volume: 258, Issue:1 Pt 1 Topics: Animals; Humans; Inflammation; Leukotrienes; Models, Biological; Platelet Activating Factor; Prostaglandins; Stomach Ulcer; Thromboxanes	1990
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. Agents and actions, 1985, Volume: 17, Issue:2 Topics: Anaphylaxis; Animals; Antigens; Cell Separation; Chemotactic Factors, Eosinophil; Disease Models, Animal; Dopamine; Histamine Release; Humans; In Vitro Techniques; Kinins; Lung; Lung Diseases; Mast Cells; Muscle Contraction; Muscle, Smooth, Vascular; Perfusion; Platelet Activating Factor; Prostaglandins; Receptors, Adrenergic, beta; Serotonin; SRS-A; Thromboxanes; Trachea	1985
Mediators of acute lung injury in endotoxaemia. Progress in clinical and biological research, 1989, Volume: 308 Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cats; Cyclooxygenase Inhibitors; Endotoxins; Escherichia coli; Lung; Lung Diseases; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Thromboxane-A Synthase; Thromboxanes	1989
[Prostaglandins and related compounds]. Masui. The Japanese journal of anesthesiology, 1988, Volume: 37, Issue:1 Topics: Animals; Arachidonic Acids; Exotoxins; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxins; Platelet Activating Factor; Prostaglandins; Thromboxanes	1988
Stimulus-response coupling mechanisms in human platelets. Agents and actions. Supplements, 1986, Volume: 20 Topics: Blood Platelets; Calcium; Cell Membrane Permeability; Contractile Proteins; Cyclic AMP; Cyclic GMP; Diglycerides; Humans; Hydrogen-Ion Concentration; Inositol Phosphates; Physical Stimulation; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins; Stimulation, Chemical; Thromboxanes; Transduction, Genetic	1986
Eicosanoids and platelet activating factor mechanisms in organ rejection. Transplantation proceedings, 1988, Volume: 20, Issue:6 Topics: Animals; Graft Rejection; Leukotrienes; Platelet Activating Factor; Prostaglandins; Thromboxanes	1988
Platelets, endothelium and blood vessel wall. Experientia, 1988, Feb-15, Volume: 44, Issue:2 Topics: Adenine Nucleotides; Animals; Blood Platelets; Blood Vessels; Coronary Vasospasm; Endothelium, Vascular; Humans; Platelet Activating Factor; Platelet Aggregation; Thromboxanes; Vasoconstriction	1988
Fatty acids and eicosanoids in organ transplantation. Progress in lipid research, 1986, Volume: 25, Issue:1-4 Topics: Animals; Fatty Acids, Unsaturated; Glucocorticoids; Humans; Platelet Activating Factor; Thromboxanes; Tissue Survival; Transplantation, Homologous	1986
Eicosanoids and the coronary circulation. Reviews of physiology, biochemistry and pharmacology, 1986, Volume: 104 Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Disease; Epoprostenol; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Platelet Activating Factor; Thromboxanes	1986
Mediators of anaphylaxis and inflammation. Annual review of microbiology, 1982, Volume: 36 Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Autacoids; Chemical Phenomena; Chemistry; Chemotactic Factors; Chemotactic Factors, Eosinophil; Histamine; Humans; Hydrolases; Inflammation; Leukocytes; Leukotriene B4; Mast Cells; Platelet Activating Factor; Prostaglandins; Serotonin; SRS-A; Structure-Activity Relationship; Thromboxanes; Vasoactive Intestinal Peptide	1982
The mast cell. Critical reviews in immunology, 1981, Volume: 3, Issue:1 Topics: Animals; Autacoids; Calcium; Cattle; Chemotactic Factors; Cytoplasmic Granules; Cytoskeleton; Dogs; Energy Metabolism; Esterases; Guinea Pigs; Heparin; Histamine Release; Humans; Hypersensitivity, Immediate; Lipid Metabolism; Lysophosphatidylcholines; Lysosomes; Mast Cells; Mice; Microtubules; Nucleotides, Cyclic; Platelet Activating Factor; Prostaglandins; Rabbits; Rats; Receptors, IgE; Receptors, Immunologic; Serotonin; Thromboxanes	1981
State--and dynamics--of the art: a current review. IgE-mediated immediate hypersensitivity reactions: cellular events and pharmacologic mediators. The Journal of asthma : official journal of the Association for the Care of Asthma, 1983, Volume: 20, Issue:3 Topics: Antigen-Antibody Complex; Basophils; Chemotactic Factors, Eosinophil; Eosinophils; Histamine Release; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Immunoglobulin G; Lymphokines; Mast Cells; Muscle, Smooth; Platelet Activating Factor; Prostaglandins F; SRS-A; Thromboxanes	1983
Platelets and atherosclerosis. Advances in nutritional research, 1983, Volume: 5 Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arteriosclerosis; Blood Platelets; Blood Vessels; Dietary Fats; Eicosapentaenoic Acid; Epoprostenol; Fatty Acids, Unsaturated; Hemostasis; Humans; Lipid Peroxides; Mitogens; Platelet Activating Factor; Platelet Aggregation; Thromboxanes	1983
[Blood platelets, prostaglandin and complement interactions in inflammation]. Przeglad lekarski, 1982, Volume: 39, Issue:6 Topics: Animals; Blood Platelets; Complement Activation; Complement System Proteins; Humans; Inflammation; Platelet Activating Factor; Prostaglandins; Rabbits; Thromboxanes	1982
Present concepts on the mechanisms of platelet aggregation. Biochemical pharmacology, 1981, Feb-15, Volume: 30, Issue:4 Topics: Adenosine Diphosphate; Animals; Carrageenan; Crotalid Venoms; Humans; Lectins, C-Type; Lysophosphatidylcholines; Membrane Lipids; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Thromboxanes; Type C Phospholipases	1981
New developments in the treatment of asthma and chronic obstructive pulmonary disease. Respiratory medicine, 1993, Volume: 87 Suppl B Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Asthma; Humans; Immunosuppression Therapy; Leukotriene Antagonists; Lung Diseases, Obstructive; Platelet Activating Factor; Thromboxanes	1993
Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome. New horizons (Baltimore, Md.), 1993, Volume: 1, Issue:4 Topics: Acetylcysteine; Adrenal Cortex Hormones; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Epoprostenol; Humans; Inflammation; Intensive Care Units; Leukotrienes; Lipid Peroxidation; Middle Aged; Platelet Activating Factor; Respiratory Distress Syndrome; Thromboxanes; Treatment Failure	1993
Specific mediator-directed therapy for gastrointestinal diseases. European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:11 Topics: Animals; Antibodies; Cyclosporine; Cytokines; Gastrointestinal Diseases; Humans; Interleukin-1; Interleukin-10; Interleukin-2; Leukotriene Antagonists; Lipoxygenase Inhibitors; Mice; Mice, Knockout; Oligonucleotides, Antisense; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Thromboxanes; Tumor Necrosis Factor-alpha	1997
Pathophysiology of burns. Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:13-14 Topics: Angiotensin II; Animals; Burns; Catecholamines; Edema; Hemodynamics; Histamine; Humans; Hypovolemia; Inflammation Mediators; Platelet Activating Factor; Prostaglandins; Serotonin; Skin; Soft Tissue Injuries; Thromboxanes; Vascular Resistance; Vasopressins	2009

Trials

2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thromboxanes

Article	Year
The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1990, Volume: 20, Issue:3 Topics: Administration, Inhalation; Adult; Biphenyl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Heptanoic Acids; Humans; Lung; Male; Methacholine Compounds; Middle Aged; Platelet Activating Factor; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes; Time Factors; Vital Capacity	1990
Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive care medicine, 2003, Volume: 29, Issue:9 Topics: Adult; Aged; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Fish Oils; Humans; Leukotrienes; Male; Middle Aged; Neutrophils; Phosphatidylinositols; Pilot Projects; Platelet Activating Factor; Shock, Septic; Superoxides; Thromboxanes	2003

Article

Year

The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1990, Volume: 20, Issue:3

Topics: Administration, Inhalation; Adult; Biphenyl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Heptanoic Acids; Humans; Lung; Male; Methacholine Compounds; Middle Aged; Platelet Activating Factor; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes; Time Factors; Vital Capacity

1990

Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation.

Intensive care medicine, 2003, Volume: 29, Issue:9

Topics: Adult; Aged; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Fish Oils; Humans; Leukotrienes; Male; Middle Aged; Neutrophils; Phosphatidylinositols; Pilot Projects; Platelet Activating Factor; Shock, Septic; Superoxides; Thromboxanes

2003

Other Studies

61 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thromboxanes

Article	Year
Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. European journal of pharmacology, 1992, Mar-17, Volume: 213, Issue:1 Topics: Alveolitis, Extrinsic Allergic; Animals; Azepines; Bronchoalveolar Lavage Fluid; Dinoprostone; Diterpenes; Econazole; Ginkgolides; Hemoglobins; Hemorrhage; Indomethacin; Lactones; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Propionates; Quinolines; Rats; Rats, Inbred Strains; Thromboxanes; Triazoles	1992
A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2 Topics: Anaphylaxis; Animals; Azepines; Biological Transport; Carbazoles; Dinoprostone; Electrolytes; Female; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Jejunum; Leukotriene Antagonists; Leukotrienes; Phospholipids; Platelet Activating Factor; Propionates; Quinolines; Rats; Thromboxanes; Triazoles	1992
Influence of SK&F 96148 on thromboxane-mediated responses in the airways of the cat. European journal of pharmacology, 1991, May-02, Volume: 197, Issue:1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Cats; Endothelins; Endotoxins; Escherichia coli; Female; Male; Phenylacetates; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Respiratory Physiological Phenomena; Respiratory System; Sulfonamides; Thromboxane A2; Thromboxanes	1991
Benzodiazepine analogues inhibit arachidonate-induced aggregation and thromboxane synthesis in human platelets. British journal of pharmacology, 1990, Volume: 101, Issue:4 Topics: Arachidonic Acid; Arachidonic Acids; Benzodiazepines; Blood Coagulation Factors; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, GABA-A; Thromboxanes	1990
[Peptic ulcer and arachidonate cascade related compounds]. Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:6 Topics: Animals; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Leukotrienes; Platelet Activating Factor; Prostaglandins; Stomach Ulcer; Thromboxanes	1990
Effect of inflammatory mediators on airway nerves and muscle. The American review of respiratory disease, 1991, Volume: 143, Issue:3 Pt 2 Topics: Acetylcholine; Animals; Bronchoconstriction; Dogs; Humans; In Vitro Techniques; Inflammation; Leukotrienes; Muscle Contraction; Muscle, Smooth; Ozone; Platelet Activating Factor; Prostaglandins; Respiratory System; Thromboxanes; Trachea	1991
Control of local blood flow in pulmonary inflammation: role for neutrophils, PAF, and thromboxane. Journal of applied physiology (Bethesda, Md. : 1985), 1991, Volume: 70, Issue:3 Topics: Animals; Complement C5a; Feedback; Female; Guinea Pigs; Hypoxia; In Vitro Techniques; Male; Neutrophils; Platelet Activating Factor; Pneumonia; Pulmonary Circulation; Rabbits; Regional Blood Flow; Thromboxanes; Vasoconstriction	1991
Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. British journal of pharmacology, 1990, Volume: 101, Issue:4 Topics: Animals; Capillary Permeability; Diterpenes; Eicosanoids; Evans Blue; Ginkgolides; Lactones; Male; Norepinephrine; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Respiratory System; SRS-A; Thromboxanes	1990
Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224. The American review of respiratory disease, 1990, Volume: 142, Issue:3 Topics: Albumins; Anaphylaxis; Animals; Asthma; Azepines; Betamethasone; Bronchoalveolar Lavage Fluid; Cell Count; Eosinophils; Guinea Pigs; Histamine; Immunization; Indomethacin; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung; Male; Naphthyridines; Ovalbumin; Platelet Activating Factor; Pyrazoles; Thromboxanes; Triazoles	1990
Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:1 Topics: Animals; Azepines; Blood Cells; Hemodynamics; Humans; Lipopolysaccharides; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Recombinant Proteins; Shock, Septic; Thromboxanes; Triazoles; Tumor Necrosis Factor-alpha	1990
Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. The Journal of clinical investigation, 1990, Volume: 85, Issue:4 Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Capillary Permeability; Drug Synergism; Endotoxins; Fatty Acids, Unsaturated; Hydrazines; Imidazoles; In Vitro Techniques; Indomethacin; Lipopolysaccharides; Lung; Perfusion; Platelet Activating Factor; Pulmonary Edema; Rabbits; Thromboxanes; Tumor Necrosis Factor-alpha	1990
Cooperativity between platelet-activating factor and collagen in aggregation of bovine platelets, II. Biochemical and biophysical research communications, 1990, May-16, Volume: 168, Issue:3 Topics: Animals; Calcium; Cattle; Collagen; Drug Synergism; Electrophoresis, Polyacrylamide Gel; In Vitro Techniques; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Signal Transduction; Thromboxanes	1990
Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counteract PAF and allergen-induced bronchial obstruction in vivo. Biochemical pharmacology, 1988, Dec-01, Volume: 37, Issue:23 Topics: Allergens; Allium; Animals; Asthma; Bronchi; Bronchial Provocation Tests; Drug Interactions; Guinea Pigs; Histamine Release; Humans; Leukocytes; Leukotrienes; Lipoxygenase Inhibitors; Plant Extracts; Platelet Activating Factor; Sulfinic Acids; Thromboxanes	1988
Hypothesis: a central role for platelet activating factor in the pathogenesis of pre-eclampsia. Medical hypotheses, 1989, Volume: 28, Issue:4 Topics: Angiotensin II; Female; Humans; Immune Tolerance; Platelet Activating Factor; Pre-Eclampsia; Pregnancy; Thromboxanes	1989
Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655,240, a new thromboxane-prostaglandin endoperoxide antagonist. Canadian journal of physiology and pharmacology, 1989, Volume: 67, Issue:4 Topics: Animals; Blood Pressure; Diuresis; Dogs; Female; Glomerular Filtration Rate; Indoles; Kidney; Natriuresis; Platelet Activating Factor; Reference Values; Renal Circulation; Thromboxanes	1989
The role of extracellular Ca2+ and Na+ in paf-acether-induced human platelet activation. Biochemical pharmacology, 1989, Oct-15, Volume: 38, Issue:20 Topics: Calcium; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Serotonin; Sodium; Thromboxanes	1989
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:3 Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan	1987
Effect of dietary fish oils on the formation of leukotriene B4 and B5, thromboxane and platelet activating factor by rat leukocytes. Clinical and experimental pharmacology & physiology, 1988, Volume: 15, Issue:7 Topics: Animals; Arachidonic Acid; Arachidonic Acids; Diet; Eicosapentaenoic Acid; Fatty Acids; Fish Oils; In Vitro Techniques; Leukocytes; Leukotriene B4; Lipoxygenase; Male; Phospholipids; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxanes	1988
Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. Advances in prostaglandin, thromboxane, and leukotriene research, 1987, Volume: 17A Topics: Animals; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Activation; Platelet Activating Factor; Rats; SRS-A; Thromboxanes; Transplantation Immunology; Transplantation, Homologous	1987
At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. Agents and actions, 1987, Volume: 22, Issue:1-2 Topics: beta-Thromboglobulin; Blood Platelets; Calcium; Female; Heparin; Hirudins; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2; Thromboxanes	1987
Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+. Nouvelle revue francaise d'hematologie, 1985, Volume: 27, Issue:4 Topics: Aminoquinolines; Blood Platelets; Calcium; Calcium Channel Blockers; Cytosol; Egtazic Acid; Fluorescent Dyes; Homeostasis; Humans; Kinetics; Phosphatidylinositols; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Thromboxanes	1985
Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. The Journal of pharmacology and experimental therapeutics, 1986, Volume: 236, Issue:3 Topics: Animals; Bronchi; Dogs; In Vitro Techniques; Leukotriene B4; Methacrylates; Neutrophils; Platelet Activating Factor; Respiratory System; Thromboxanes	1986
Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung. Pharmacological research communications, 1986, Volume: 18 Suppl Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Dinoprostone; Diterpenes; Female; Ginkgolides; Guinea Pigs; In Vitro Techniques; Kinetics; Lactones; Lung; Male; Ovalbumin; Plant Extracts; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Thromboxane B2; Thromboxanes	1986
Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. Prostaglandins, 1986, Volume: 32, Issue:3 Topics: Adenosine Diphosphate; Adolescent; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Collagen; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2; Thromboxanes	1986
Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms. The Biochemical journal, 1986, Dec-01, Volume: 240, Issue:2 Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fibrinogen; Humans; Indomethacin; Kinetics; Macromolecular Substances; Platelet Activating Factor; Prostaglandin Endoperoxides; Protein Binding; Thromboxanes	1986
Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart. Advances in prostaglandin, thromboxane, and leukotriene research, 1985, Volume: 13 Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Circulation; Heart; Myocardium; Platelet Activating Factor; SRS-A; Swine; Thromboxane B2; Thromboxanes	1985
PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. Prostaglandins, 1988, Volume: 36, Issue:5 Topics: Animals; Capillary Permeability; Diterpenes; Evans Blue; Ginkgolides; Indoles; Lactones; Male; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Thromboxanes; Tissue Distribution	1988
Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. Biomedica biochimica acta, 1987, Volume: 46, Issue:8-9 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arrhythmias, Cardiac; Epoprostenol; Fatty Acids, Unsaturated; Guinea Pigs; Male; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes	1987
Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. Thrombosis and haemostasis, 1988, Apr-08, Volume: 59, Issue:2 Topics: Blood Platelets; Calcium; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Thrombin; Thromboxanes	1988
Human platelet aggregation by PAF and thromboxane production. Thrombosis research, 1987, Oct-15, Volume: 48, Issue:2 Topics: Blood Coagulation Factors; Blood Platelets; Humans; Platelet Activating Factor; Platelet Aggregation; Thromboxanes	1987
Platelets, endothelium, and vasospasm. Circulation, 1985, Volume: 72, Issue:4 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Dinoprost; Endothelium; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandins F; Serotonin; Thromboxanes; Vasoconstriction	1985
[Cell membrane and phospholipids]. Archives des maladies du coeur et des vaisseaux, 1985, Volume: 78 Spec No Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Cell Membrane; Humans; Lysophosphatidylcholines; Membrane Lipids; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Prostaglandins; SRS-A; Thromboxanes; Type C Phospholipases	1985
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. Archives des maladies du coeur et des vaisseaux, 1985, Volume: 78 Spec No Topics: Arachidonic Acids; Blood Platelets; Blood Vessels; Cell Membrane; Endothelium; Humans; Leukocytes; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Phospholipids; Platelet Activating Factor; Prostaglandins; SRS-A; Thrombosis; Thromboxanes	1985
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. Advances in prostaglandin, thromboxane, and leukotriene research, 1983, Volume: 11 Topics: Adenosine Diphosphate; Drug Synergism; Epinephrine; Humans; Kinetics; Platelet Activating Factor; Platelet Aggregation; Thromboxane A2; Thromboxanes	1983
Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. Biochimica et biophysica acta, 1982, Jun-11, Volume: 711, Issue:3 Topics: Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Epoprostenol; Humans; Indomethacin; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes	1982
Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7. FEBS letters, 1983, Aug-22, Volume: 160, Issue:1-2 Topics: Animals; Guinea Pigs; Macrophages; Oxygen; Platelet Activating Factor; Prostaglandins E; Sulfonamides; Superoxides; Thromboxane B2; Thromboxanes; Vasodilator Agents	1983
The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. British journal of pharmacology, 1984, Volume: 82, Issue:3 Topics: Aerosols; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bradykinin; Female; In Vitro Techniques; Lung; Male; Mice; Muscle Contraction; Muscle, Smooth; Perfusion; Platelet Activating Factor; SRS-A; Thromboxane A2; Thromboxanes	1984
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. American journal of hematology, 1984, Volume: 17, Issue:2 Topics: Adenosine; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelet Disorders; Humans; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thrombin; Thromboxanes	1984
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. Agents and actions. Supplements, 1983, Volume: 13 Topics: Anaphylaxis; Animals; Blood Platelets; Bronchi; Guinea Pigs; Histamine; In Vitro Techniques; Lipid Metabolism; Lung; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Rabbits; SRS-A; Thromboxanes	1983
[Effects of platelet activating factor (PAF:AGEPC) on airway and pulmonary vascular constriction of guinea pigs--with special reference to the relation with TXA2]. Kokyu to junkan. Respiration & circulation, 1983, Volume: 31, Issue:7 Topics: Airway Resistance; Animals; Female; Guinea Pigs; Platelet Activating Factor; Pulmonary Artery; Thromboxane A2; Thromboxanes; Vasoconstriction	1983
Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. Immunopharmacology, 1983, Volume: 5, Issue:3 Topics: Animals; Blood Platelets; Female; Male; Platelet Activating Factor; Platelet Count; Platelet Factor 4; Rabbits; Serotonin; Thromboxane B2; Thromboxanes	1983
Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2. Chest, 1983, Volume: 83, Issue:5 Suppl Topics: Albumins; Animals; Blood Platelets; Hypertension, Pulmonary; Lung; Neutrophils; Platelet Activating Factor; Pulmonary Edema; Rabbits; Thromboxane A2; Thromboxanes	1983
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action. Agents and actions, 1982, Volume: 12, Issue:5-6 Topics: Animals; Drug Synergism; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thromboxanes	1982
Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). Biochimica et biophysica acta, 1981, Jan-26, Volume: 663, Issue:1 Topics: Animals; Arachidonic Acids; Blood Platelets; Dose-Response Relationship, Drug; Glycerides; Kinetics; Lysophosphatidylcholines; Phospholipases; Phospholipids; Platelet Activating Factor; Rabbits; Serotonin; Thromboxane B2; Thromboxanes	1981
Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. Laboratory investigation; a journal of technical methods and pathology, 1981, Volume: 45, Issue:4 Topics: Animals; Blood Cell Count; Blood Coagulation Factors; Blood Proteins; Hematocrit; Infusions, Parenteral; Lysophosphatidylcholines; Neutropenia; Papio; Platelet Activating Factor; Platelet Factor 4; Species Specificity; Thrombocytopenia; Thromboxane B2; Thromboxanes	1981
Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2. The American journal of physiology, 1995, Volume: 268, Issue:5 Pt 2 Topics: Animals; Azepines; Blood Pressure; Capillary Permeability; Hindlimb; Ibuprofen; Male; Phenylacetates; Platelet Activating Factor; Rats; Rats, Wistar; Regional Blood Flow; Sulfonamides; Thromboxane A2; Thromboxanes; Triazoles; Vascular Resistance	1995
Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. Journal of applied physiology (Bethesda, Md. : 1985), 1994, Volume: 77, Issue:1 Topics: Animals; Bronchoconstriction; Capillary Permeability; Cyclooxygenase Inhibitors; Female; Leukotrienes; Lipoxygenase Inhibitors; Lung; Organ Size; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Thromboxane; Thromboxanes; Vasoconstriction	1994
ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations. Thrombosis research, 1994, Aug-01, Volume: 75, Issue:3 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Calcium; Citric Acid; Collagen; Epinephrine; Glucose; Hirudins; Humans; Indomethacin; Phenylacetates; Platelet Activating Factor; Platelet Aggregation; Receptors, Thromboxane; Recombinant Proteins; Sulfonamides; Thromboxanes	1994
Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol. The Journal of pharmacy and pharmacology, 1994, Volume: 46, Issue:1 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Blood Platelets; Collagen; Cyclic AMP; Eugenol; Humans; Membrane Lipids; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thrombin; Thromboxanes	1994
Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. The American journal of physiology, 1993, Volume: 265, Issue:1 Pt 2 Topics: Animals; Antibodies; Complement C5a; Female; Glomerular Filtration Rate; Hydronephrosis; Indazoles; Neutrophils; Phenylacetates; Platelet Activating Factor; Rats; Rats, Wistar; Recombinant Proteins; Reference Values; Renal Circulation; SRS-A; Sulfonamides; Thromboxanes; Vasoconstriction	1993
Effect of urodilatin on platelet-activating factor-induced bronchoconstriction, vasoconstriction and edema formation in isolated rat lung. Naunyn-Schmiedeberg's archives of pharmacology, 1996, Volume: 354, Issue:5 Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Bronchoconstriction; Bronchodilator Agents; Capillary Permeability; Edema; Female; Lung; Organ Size; Peptide Fragments; Perfusion; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxanes; Vascular Resistance; Vasoconstriction	1996
Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:5 Topics: Animals; Azepines; Bronchi; Bronchial Hyperreactivity; Chromones; Indoles; Indomethacin; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Lung; Methacrylates; Mice; Mice, Transgenic; Phenylpropionates; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Thromboxanes; Triazoles	1997
Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs. Journal of applied physiology (Bethesda, Md. : 1985), 1997, Volume: 83, Issue:5 Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascaris suum; Blood Pressure; Capillary Permeability; Dogs; Eicosanoids; Female; Histamine; Histamine H1 Antagonists; In Vitro Techniques; Leukocyte Count; Lung; Male; Platelet Activating Factor; Pulmonary Circulation; Thromboxanes; Vasoconstriction	1997
Bacterial lipopolysaccharide induction of the prostaglandin G/H synthase 2 gene causes thromboxane-dependent pulmonary hypertension in rabbits. American journal of respiratory cell and molecular biology, 1999, Volume: 20, Issue:3 Topics: Animals; Arachidonic Acid; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Dactinomycin; Drug Interactions; Enzyme Induction; Female; Hypertension, Pulmonary; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rabbits; Thromboxanes	1999
Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochemical pharmacology, 1999, Oct-01, Volume: 58, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Calcium; Curcuma; Curcumin; Cyclooxygenase Inhibitors; Drug Interactions; Humans; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Spices; Thromboxanes	1999
Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. European journal of pharmacology, 2000, Aug-18, Volume: 402, Issue:1-2 Topics: Albumins; Animals; Capillary Permeability; Enzyme Inhibitors; Inflammation; Laparotomy; Leukotrienes; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxanes	2000
Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 287, Issue:1 Topics: Amides; Animals; Bronchoconstriction; Enzyme Inhibitors; Female; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Lung; Platelet Activating Factor; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; Thromboxanes; Vasoconstriction	2004
Prostaglandins & other lipid mediators: a new phase, a new team. Prostaglandins & other lipid mediators, 2004, Volume: 73, Issue:1-2 Topics: Computer Communication Networks; Eicosanoids; Leukotrienes; Platelet Activating Factor; Prostaglandins; Publications; Research; Thromboxanes	2004
Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. Biochemical and biophysical research communications, 2006, Jul-07, Volume: 345, Issue:3 Topics: Animals; Arachidonic Acid; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Models, Chemical; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Sesquiterpenes; Sesquiterpenes, Guaiane; Thromboxanes	2006
Platelets in equine recurrent airway obstruction. Research in veterinary science, 2007, Volume: 82, Issue:3 Topics: Animals; Antigens; Blood Platelets; Horse Diseases; Horses; Hypersensitivity; Lung Diseases, Obstructive; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thromboxanes; Time Factors	2007
Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases. Journal of veterinary pharmacology and therapeutics, 2009, Volume: 32, Issue:2 Topics: Analysis of Variance; Animals; Horses; Lipopolysaccharides; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphotransferases; Platelet Activating Factor; Platelet Activation; Protein Kinase C; Serotonin; Thromboxanes	2009